Vanderbilt scientists report first effective medical therapy for rare stomach disorder

(Vanderbilt University Medical Center) A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report in the Nov. 25 issue of the journal Science Translational Medicine.The targeted cancer drug cetuximab, brand name Erbitux, relieved symptoms of severe Ménétrier’s disease in seven patients who completed a one-month course of treatment. Four of them showed near-complete remission, the researchers report.

source : www.eurekalert.org

Related News:

• Celebrating 30 Years Of Innovation In Neuromodulation, St. Jude Medical Unveils Latest Product At American Academy Of Pain Medicine Annual Meeting
• Fresenius Medical Care Sends Dialysis Supplies For Haiti Relief Effort
• Even medical students want conventional medicine to include alternative therapies
• RXi Pharmaceuticals And The University Of Massachusetts Medical School Announce Research Collaboration Focused On Ocular Disease
• AIDS: The great medical con, explained by David Icke
• MRI Injury Prompts Recall of Medical Blanket
• University Of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient With Leksell Gamma Knife Radiosurgery System
• Bedside Skills Trump Medical Technology
• The Top 10 Medical Advances of the Decade
• British Medical Association Cymru Wales Backs Private Members Bill To Regulate Suntan Salons

Details :
Submited at Wednesday, November 25th, 2009 at 7:00 pm on Cancer and Oncology by ethan
Comment RSS 2.0 - leave a comment - trackback